agilon health, inc.
جودة البيانات: 100%
AGL
NYSE
Services
Health Services
KWD 19.83
▲
KWD 1.36
(7.36%)
القيمة السوقية: 329.30 M
السعر
KWD 19.83
القيمة السوقية
329.30 M
نطاق اليوم
KWD 16.54 — KWD 19.91
نطاق 52 أسبوعًا
KWD 7.48 — KWD 144.25
حجم التداول
330,969
فتح KWD 18.38
متوسط 50 يوم / 200 يوم
KWD 14.04
41.20% above
متوسط 50 يوم / 200 يوم
KWD 25.62
22.59% below
Quick Summary
النقاط الرئيسية
Revenue grew 34.12% annually over 5 years — strong growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -119.01 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 36.23%
Capital efficient — spends only 0.22% of revenue on capex
النمو
Revenue Growth (5Y)
34.12%
أعلى من متوسط القطاع (3.99%)
Revenue (1Y)-2.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-109.47%
أقل من متوسط القطاع (-15.95%)
ROIC-89.24%
Net Margin-6.60%
Op. Margin-7.81%
الأمان
Debt / Equity
0.00
أقل من متوسط القطاع (0.39)
Current Ratio1.08
Interest Coverage-69.75
التقييم
PE (TTM)
-0.84
أعلى من متوسط القطاع (-1.17)
P/B Ratio1.08
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)
مقارنة الأقران
مقابل وسيط قطاع Services (502 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.8 | -1.2 |
| P/B | 1.1 | 1.4 |
| ROE % | -109.5 | -16.0 |
| Net Margin % | -6.6 | -19.4 |
| Rev Growth 5Y % | 34.1 | 4.0 |
| D/E | 0.0 | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.11% | Revenue Growth (3Y) | 17.24% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 34.12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.93 B | Net Income (TTM) | -391.35 M |
| ROE | -109.47% | ROA | -23.65% |
| Gross Margin | N/A | Operating Margin | -7.81% |
| Net Margin | -6.60% | Free Cash Flow (TTM) | -119.01 M |
| ROIC | -89.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.08 |
| Interest Coverage | -69.75 | Asset Turnover | 3.59 |
| Working Capital | 98.15 M | Tangible Book Value | 206.69 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.84 | Forward P/E | N/A |
| P/B Ratio | 1.08 | P/S Ratio | 0.06 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -36.14% | ||
| Market Cap | 329.30 M | Enterprise Value | 157.62 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 357.25 |
| FCF / Share | -7.17 | OCF / Share | -6.37 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.22% | FCF Conversion | 30.41% |
| SBC-Adj. FCF | -171.86 M | Growth Momentum | -36.23 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.93 B | 6.06 B | 4.32 B | 2.71 B | 1.83 B |
| Net Income | -391.35 M | -260.15 M | -262.60 M | -106.55 M | -406.49 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -463.24 M | -292.13 M | -232.13 M | -120.43 M | -393.95 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 28.59 M | 24.46 M | 20.16 M | 13.77 M | 14.67 M |
| Interest Expense | 6.64 M | 6.18 M | 6.66 M | 4.53 M | 6.15 M |
| Income Tax | 1.25 M | 1.45 M | 791,000.0 | 1.64 M | 886,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.27 B | 1.73 B | 1.74 B | 1.70 B | 1.59 B |
| Total Liabilities | 1.14 B | 1.26 B | 1.08 B | 656.86 M | 494.66 M |
| Shareholders' Equity | 126.73 M | 470.95 M | 661.84 M | 1.04 B | 1.09 B |
| Total Debt | 34.99 M | 34.90 M | 38.56 M | 43.75 M | 48.75 M |
| Cash & Equivalents | 173.71 M | 188.23 M | 107.57 M | 497.07 M | 1.04 B |
| Current Assets | 1.10 B | 1.46 B | 1.48 B | 1.45 B | 1.37 B |
| Current Liabilities | 1.08 B | 1.15 B | 977.16 M | 535.09 M | 356.96 M |
{"event":"ticker_viewed","properties":{"ticker":"AGL","listing_kind":"stock","pathname":"/stocks/agl","exchange":"NYSE","country":"US"}}






